Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

BC-N102 suppress breast cancer tumorigenesis by interfering with cell cycle regulatory proteins and hormonal signaling, and induction of time-course arrest of cell cycle at G1/G0 phase

International Journal of Biological Sciences(2021)10.7150/ijbs.62808Source: DataRank Database

BC-N102 suppress breast cancer tumorigenesis by interfering with cell cycle regulatory proteins and hormonal signaling, and induction of time-course arrest of cell cycle at G1/G0 phase is a research paper published in International Journal of Biological Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 1.05)OA: goldTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Yu-Cheng Kuo ORCID,Alexander T.H. Wu ORCID,Hsu‐Shan Huang ORCID,Bashir Lawal ORCID

Live enrichment

PubMed:34421361 PMC:PMC8375223 OpenAlex:https://openalex.org/W3188164399

FWCI

1.05

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

goldLicense: cc-by-nc

journalhttps://www.ijbs.com/v17p3224.pdf

publisherhttps://www.ijbs.com/v17p3224.pdf

publisherhttps://www.ijbs.com/v17p3224.htm

journalhttps://doi.org/10.7150/ijbs.62808

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34421361

Fields of Study

Cancer-related Molecular PathwaysUbiquitin and proteasome pathwaysEpigenetics and DNA Methylation

MeSH Terms

AnimalsAntineoplastic AgentsBreast NeoplasmsCell DivisionFemaleFlow CytometryHumansMice, NudeReceptors, EstrogenBiomarkers, TumorBlotting, WesternGene Expression Regulation, NeoplasticResting Phase, Cell CycleG1 PhaseCell Cycle ProteinsMaximum Tolerated DoseXenograft Model Antitumor AssaysCell Line, TumorCyclin-Dependent Kinase 2Cyclin-Dependent Kinase 4MiceCell Cycle Checkpoints

Keywords

Cancer researchEstrogen receptorCyclin-dependent kinase 6Signal transductionProtein kinase BCell cycleBreast cancerMAPK/ERK pathwayBiologyCarcinogenesisCancerKinaseCyclin-dependent kinase 2Protein kinase AEndocrinologyInternal medicineCell biologyMedicineCell cycle proteinsChromatin ImmunoprecipitationTumor ProgressionHormonal SignalingEr+ Breast CancerG1/G0 Cell Cycle Arrest

Sustainable Development Goals

SDG 0: Good health and well-being